Varma Mutual Pension Insurance CO Argenx Se Transaction History

Varma Mutual Pension Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$356.01 - $451.55 $356,010 - $451,550	1,000 Added 20.0%	6,000 $2.58 Million
Q1 2024 May 13, 2024	BUY	$356.95 - $413.29 $1.78 Million - $2.07 Million	5,000 New	5,000 $1.97 Million
Q2 2023 Aug 11, 2023	SELL	$360.14 - $422.58 $1.8 Million - $2.11 Million	-5,000 Reduced 25.0%	15,000 $5.85 Million
Q1 2023 May 11, 2023	BUY	$334.23 - $403.65 $6.68 Million - $8.07 Million	20,000 New	20,000 $7.45 Million

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Varma Mutual Pension Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Varma Mutual Pension Insurance CO with notifications on news.